Trials & R&D · first seen yesterday, updated yesterday
Safety Concerns Halt Depression Trials; Gen Z and Alcohol; Prescribing Benzos
(MedPage Today) -- Xenon Pharmaceuticals said it paused enrollment in its major depressive disorder and bipolar depression trials after unexpected neuropsychiatric adverse events emerged. Many mental health and suicide risk indicators among…
Summary from MedPage Today.